Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2011 | 06-2011 | 05-2011 | 03-2011 | 02-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,320 | -1,320 | N/A | -835 | -835 |
| Depreciation Amortization | 52 | 52 | 55 | 55 | 55 |
| Accounts payable and accrued liabilities | N/A | 38 | N/A | -43 | N/A |
| Other Working Capital | 349 | 349 | 81 | 81 | 81 |
| Other Operating Activity | 590 | 551 | 508 | 552 | 508 |
| Operating Cash Flow | $-329 | $-329 | $644 | $-191 | $-191 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -47 | -47 | -43 | -43 | -43 |
| Investing Cash Flow | $-47 | $-47 | $-43 | $-43 | $-43 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 50 | N/A | 50 | N/A |
| Common Stock Issued | N/A | 205 | N/A | 140 | N/A |
| Other Financing Activity | 255 | 0 | 190 | 0 | 190 |
| Financing Cash Flow | $255 | $255 | $190 | $190 | $190 |
| Beginning Cash Position | 128 | 128 | N/A | 128 | 128 |
| End Cash Position | 7 | 7 | N/A | 84 | 84 |
| Net Cash Flow | $-121 | $-121 | $791 | $-44 | $-44 |
| Free Cash Flow | |||||
| Operating Cash Flow | -329 | -329 | 644 | -191 | -191 |
| Capital Expenditure | N/A | -47 | N/A | -43 | N/A |
| Free Cash Flow | -329 | -376 | 644 | -234 | -191 |